mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 10, Pages 1060
Publisher
MDPI AG
Online
2021-09-28
DOI
10.3390/vaccines9101060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Vaccines: Antigen Selection Strategy
- (2021) Yue Zhao et al. Vaccines
- mRNA vaccine: a potential therapeutic strategy
- (2021) Yang Wang et al. Molecular Cancer
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- mRNA in cancer immunotherapy: beyond a source of antigen
- (2021) Lien Van Hoecke et al. Molecular Cancer
- A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
- (2020) Srinivas Ramishetti et al. ADVANCED MATERIALS
- The challenge and prospect of mRNA therapeutics landscape
- (2020) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
- (2020) Steve Boudewijns et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
- (2020) Brenda De Keersmaecker et al. Journal for ImmunoTherapy of Cancer
- Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
- (2020) Alexey V. Baldin et al. Cancers
- Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
- (2020) Abishek Wadhwa et al. Pharmaceutics
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
- (2020) Yanina Jansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Self-Amplifying RNA Viruses as RNA Vaccines
- (2020) Kenneth Lundstrom INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
- (2020) Annalisa Del Prete et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Impact of mRNA chemistry and manufacturing process on innate immune activation
- (2020) Jennifer Nelson et al. Science Advances
- Impact of high tumor mutational burden in solid tumors and challenges for biomarker application
- (2020) Mairéad G. McNamara et al. CANCER TREATMENT REVIEWS
- Electroporation as a method of choice to generate genetically modified dendritic cell cancer vaccines
- (2020) Rita Ahmed et al. CURRENT OPINION IN BIOTECHNOLOGY
- Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
- (2019) Susannah L. Hewitt et al. Science Translational Medicine
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Immune therapy of melanoma: Overview of therapeutic vaccines
- (2019) Zahra Payandeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
- (2019) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
- (2019) ANA Maria Arance Fernandez et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
- (2019) Caroline Robert et al. LANCET ONCOLOGY
- A trans-amplifying RNA vaccine strategy for induction of potent protective immunity
- (2019) Tim Beissert et al. MOLECULAR THERAPY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery
- (2019) Melissa P. Lokugamage et al. ADVANCED MATERIALS
- Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide
- (2019) Yingshan Qiu et al. JOURNAL OF CONTROLLED RELEASE
- A “top-down” approach to actuate poly(amine- co -ester) terpolymers for potent and safe mRNA delivery
- (2018) Yuhang Jiang et al. BIOMATERIALS
- Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells
- (2018) A. Le Moignic et al. JOURNAL OF CONTROLLED RELEASE
- Recent advances in mRNA vaccine delivery
- (2018) Lu Tan et al. Nano Research
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
- (2018) Alex Rubinsteyn et al. Frontiers in Immunology
- mRNA polyplexes with post-conjugated GALA peptides efficiently target, transfect and activate antigen presenting cells
- (2018) Bo Lou et al. BIOCONJUGATE CHEMISTRY
- Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
- (2018) Martin P. Stewart et al. CHEMICAL REVIEWS
- mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446
- (2018) Glenn D. Bell et al. PLoS One
- Mechanism of action of mRNA-based vaccines
- (2017) Carlo Iavarone et al. Expert Review of Vaccines
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
- (2017) S Guan et al. GENE THERAPY
- Poloxamers, poloxamines and polymeric micelles: Definition, structure and therapeutic applications in cancer
- (2017) Mauro Almeida et al. JOURNAL OF POLYMER RESEARCH
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Arginine-Rich Peptide-Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the Peptide
- (2017) Vimal K. Udhayakumar et al. Advanced Healthcare Materials
- Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date
- (2017) Amélie Boespflug et al. Therapeutic Advances in Medical Oncology
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Role of Cell Membrane–Vector Interactions in Successful Gene Delivery
- (2016) Sriram Vaidyanathan et al. ACCOUNTS OF CHEMICAL RESEARCH
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
- (2016) Abderraouf Selmi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumour-associated antigens and their anti-cancer applications
- (2016) C.-C. Liu et al. EUROPEAN JOURNAL OF CANCER CARE
- Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines
- (2016) Ronald J Fecek et al. Immunotherapy
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems
- (2016) Mehdi Rezaee et al. JOURNAL OF CONTROLLED RELEASE
- Viral and Synthetic RNA Vector Technologies and Applications
- (2016) Juliane W Schott et al. MOLECULAR THERAPY
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma
- (2016) Stephan Grabbe et al. Nanomedicine
- Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines
- (2016) Thomas Démoulins et al. Nanomedicine-Nanotechnology Biology and Medicine
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Immune checkpoint combinations from mouse to man
- (2015) Midan Ai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA
- (2015) Mengnan Zhao et al. DRUG DELIVERY
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Mechanistic profiling of the siRNA delivery dynamics of lipid–polymer hybrid nanoparticles
- (2015) Stefano Colombo et al. JOURNAL OF CONTROLLED RELEASE
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- mRNA: Fulfilling the Promise of Gene Therapy
- (2015) Drew Weissman et al. MOLECULAR THERAPY
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Suppression of T cell responses in the tumor microenvironment
- (2015) Alan B. Frey VACCINE
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Intralymphatic immunotherapy
- (2015) Gabriela Senti et al. World Allergy Organization Journal
- Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
- (2015) Kevin Van der Jeught et al. Oncotarget
- Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
- (2014) Sofie Wilgenhof et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
- (2014) Raquel P Deering et al. Expert Opinion on Drug Delivery
- Lipid-based mRNA vaccine delivery systems
- (2014) Patrick Midoux et al. Expert Review of Vaccines
- Human Tyrosinase Produced in Insect Cells: A Landmark for the Screening of New Drugs Addressing its Activity
- (2014) Stefano Fogal et al. MOLECULAR BIOTECHNOLOGY
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
- (2014) Luis A Brito et al. MOLECULAR THERAPY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Quantitative Measurement of Melanoma Spread in Sentinel Lymph Nodes and Survival
- (2014) Anja Ulmer et al. PLOS MEDICINE
- Multifunctional polymeric micelles for delivery of drugs and siRNA
- (2014) Aditi M. Jhaveri et al. Frontiers in Pharmacology
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Potential therapeutic applications of RNA cap analogs
- (2013) Marcin Ziemniak et al. Future Medicinal Chemistry
- Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update
- (2013) Nelson G. Ordóñez HUMAN PATHOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Tumor Subtype-Specific Cancer-Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
- (2013) J. Yao et al. Cancer Immunology Research
- Peptide Vectors for the Nonviral Delivery of Nucleic Acids
- (2012) Jan Hoyer et al. ACCOUNTS OF CHEMICAL RESEARCH
- Protein and non-protein biomarkers in melanoma: a critical update
- (2012) Nadine Tandler et al. AMINO ACIDS
- PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN- Inducible Chemokines
- (2012) W. Peng et al. CANCER RESEARCH
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
- (2012) E. H. J. G. Aarntzen et al. CLINICAL CANCER RESEARCH
- mRNA as a Versatile Tool for Exogenous Protein Expression
- (2012) Andreas N. Kuhn et al. CURRENT GENE THERAPY
- Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients
- (2012) An MT Van Nuffel et al. MOLECULAR THERAPY
- Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
- (2012) Katalin Karikó et al. MOLECULAR THERAPY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- Picornavirus Modification of a Host mRNA Decay Protein
- (2012) J. M. Rozovics et al. mBio
- Influence of Nano-Carrier Architecture on in Vitro siRNA Delivery Performance and in Vivo Biodistribution: Polyplexes vs Micelleplexes
- (2011) Dana J. Gary et al. ACS Nano
- mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells
- (2011) Marie-Luce De Temmerman et al. BIOMATERIALS
- Recombinant AAV-directed gene therapy for type I glycogen storage diseases
- (2011) Janice Y Chou et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- (2011) M Diken et al. GENE THERAPY
- Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
- (2011) Xian-Zhu Yang et al. JOURNAL OF CONTROLLED RELEASE
- Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets
- (2011) Oleg O. Markov et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma
- (2011) Sofie Wilgenhof et al. JOURNAL OF IMMUNOTHERAPY
- BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
- (2011) E. R. Cantwell-Dorris et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
- (2011) Federico Perche et al. Nanomedicine-Nanotechnology Biology and Medicine
- PEGylation Improves Nanoparticle Formation and Transfection Efficiency of Messenger RNA
- (2011) Senta Üzgün et al. PHARMACEUTICAL RESEARCH
- Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway
- (2011) Christina Lorenz et al. RNA Biology
- MAGE-A family: Attractive targets for cancer immunotherapy
- (2011) Meixiang Sang et al. VACCINE
- A Role for Codon Order in Translation Dynamics
- (2010) Gina Cannarozzi et al. CELL
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
- (2010) V. F. Van Tendeloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients
- (2009) A. Bonehill et al. CLINICAL CANCER RESEARCH
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- High-Level Antigen Expression and Sustained Antigen Presentation in Dendritic Cells Nucleofected with Wild-Type Viral mRNA but Not DNA
- (2008) N. M. Melhem et al. Clinical and Vaccine Immunology
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started